ArticleInternational wound journal2025
The infected diabetic foot: Bacteraemia and endocarditis complicating moderate and severe foot infections.
Article in International wound journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The infected diabetic foot: Bacteraemia and endocarditis complicating moderate and severe foot infections.International wound journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To identify the incidence of blood stream infections (BSIs) and endocarditis in patients with diabetic foot infections (DFIs), risk factors and clinical outcomes. A post hoc analysis of 280 patients using pooled patient level data from three RTCs. Blood cultures were drawn at time of admission for DFI. Deep intraoperative cultures were obtained from infected foot wounds. Data from the 12-month follow-up were used to determine clinical outcomes. 77.1% (N = 216) had blood cultures of which 15.7% (n = 34) had BSI. One patient (3.3%) had endocarditis. Risk factors for BSI included Charcot Neuroarthropathy history (20.6% vs. 7.1%, p = 0.03), low systolic blood pressure (128.3 ± 21.0 vs. 140.8 ± 22.2 p = 0.003), low diastolic blood pressure (71.6 ± 9.4 vs. 79.3 ± 11.5 p <0.001), leucocytosis >12 000 (55.9% vs. 29.1%, p = 0.002) and elevated C-reactive protein (CRP) (26.8 ± 31.2 vs. 12.0 ± 19.6, p <0.001). During the index hospitalization, BSI patients had longer median hospitalizations (14.0, 11.3-18.0 vs. 12.0, 9.0-16.0, p = 0.04). At 12-months, BSI patients were more likely to be admitted to the hospital (all cause hospital admissions 35.3% vs. 18.6%, p = 0.03). There was no difference in re-infection (20.6% vs. 32.9%, p = 0.21), foot-specific hospitalizations (17.6% vs. 22.5%, p = 0.65), wounds healing (64.7% vs. 67.5%, p = 0.88), time to heal (221.0, 74.0-365 vs. 109.5, 46.8-365, p = 0.16) or antibiotic duration (46.0, 39.3-76.5 vs. 45.0, 22.3-67.0, p = 0.09). The most common BSI pathogens were Staphylococcus aureus (79.4%) and Streptococcus spp. (50.0%) species. BSI is common in DFIs. Patients have longer hospitalizations and were more likely to be hospitalized after their initial discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.